The 20 Best Fibrolamellar Carcinoma Doctors Near Me in Michigan, US

Mishal Mendiratta is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Mendiratta is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Visceromegaly, and Cholangiocarcinoma (Bile Duct Cancer).

William Masch is a Radiologist practicing medicine in Ypsilanti, Michigan. Dr. Masch is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Fibrolamellar Carcinoma, Alcoholic Cirrhosis, and Jaundice.

John Fallucca is a Radiologist practicing medicine in Troy, Michigan. Dr. Fallucca is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Chylous Ascites, Kimura Disease, Gastrostomy, and Liver Embolization.

I am a transplant hepatologist and clinical researcher committed to the care of patients with liver cancer and advanced liver disease. I serve as the Medical Director of the Multidisciplinary Liver Tumor Clinic and Medical Director of the Living Donor Liver Transplantation Program. I believe that patients should have an active voice in their care and I work jointly with patients to ensure that their needs are met. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Cirrhosis, Ascites, Liver Transplant, and Endoscopy. Dr. Parikh is board certified in Gastroenterology and Transplant Hepatology.

Dr. Nataliya Razumilava speaks English and Russian.Dr. Razumilava is a physician-scientist with a clinical and research expertise in biliary disorders (cholangiopathies) and liver cancer. She serves as the Associate Director of the Liver Tumor Program at the University of Michigan. After completion of her fellowships at the Mayo Clinic, Rochester, MN, Dr. Razumilava joined the University of Michigan in 2015 to develop a translational program focused on processes underlying inflammation-driven bile duct damage leading to bile duct regeneration as opposed to progression to fibrosis and cancer. Her research is funded by external (NIDDK, AASLD, AHA, Gilead) and internal awards. In additional to clinical care and research, she is actively involved in professional societies academic activities including education. Dr. Razumilava is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Sclerosing Cholangitis, Cholangitis, Liver Cancer, and Liver Transplant. Dr. Razumilava is board certified in Gastroenterology and Transplant Hepatology.

Christopher Sonnenday, M.D., M.H.S., is the Darrell A. Campbell, Jr, M.D., Collegiate Professor of Transplant Surgery at the University of Michigan and Transplant Center Director for University of Michigan Health. He serves as Executive Vice Chair of the Department of Surgery, Surgical Director of Living Donor Liver Transplantation, and Surgical Director of the Multidisciplinary Liver Tumor Program for Michigan Medicine. He is a Professor in the Department of Surgery, Section of Transplantation, and Professor of Health Management and Policy at the School of Public Health. Dr. Sonnenday received his medical degree from Vanderbilt University in 1997, and completed his General Surgery residency at the Johns Hopkins University in 2005. While a research fellow in transplantation from 2000 to 2003, he completed a Masters of Health Sciences in Clinical Investigation at the Bloomberg School of Public Health. After completion of his residency, Dr. Sonnenday continued at Johns Hopkins as a Fellow in Surgical Oncology and Instructor of Surgery until 2006, and he completed a fellowship in abdominal transplant surgery at the University of Michigan in 2008. His primary academic and research interests include the study of frailty in liver transplant candidates, machine perfusion in liver transplantation, the overlap of transplant and oncology, quality collaboratives in transplantation, and leadership development in academic surgery.Clinical Specialization: Dr. Sonnenday's clinical interests focus on liver transplantation, hepatobiliary and pancreatic surgery, and general surgery procedures in patients with advanced liver disease. He sees patients in the Multidisciplinary Liver Tumor Clinic at the University of Michigan Rogel Cancer Center and the Transplant Clinic at the Taubman Center. Dr. Sonnenday is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bile Duct Cysts, Liver Failure, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy. Dr. Sonnenday is board certified in Surgery.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy. Dr. Cuneo is board certified in Radiation Oncology.

Evan Glazer, MD, PhD, FACS, is the Clinical Director of the Pancreatic Cancer Program at Michigan Medicine and the Associate Director of Clinical Research in the Rogel and Blondy Center for Pancreatic Cancer. Dr. Glazer earned his medical degree and a master's degree in public health at the George Washington University in Washington, DC. Subsequently, he completed residency in general surgery and completed a PhD in Cancer Biology at the University of Arizona, in Tucson, AZ. Dr. Glazer completed an NIH funded T32 training fellowship at the M.D. Anderson Cancer Center in Houston, TX. He completed a fellowship in complex general surgical oncology at the H. Lee Moffitt Cancer Center in Tampa, FL. Dr. Glazer is board certified in complex general surgical oncology and general surgery. His clinical and research focuses are on pancreatic and liver malignancies.After completing fellowship in Tampa, Dr. Glazer joined the University of Tennessee Health Science Center in Memphis, TN, and rose in rank to Associate Professor. He served as program director of the complex general surgical oncology fellowship there as well as associate program director for research in the general surgery residency program. Dr. Glazer is a member of the American College of Surgeons, American Association for Cancer Research, Society of Surgical Oncology, Association of Academic Surgery, and American Society of Clinical Oncology. With a national reputation, he has served on the Hepatobiliary Panel and Pancreatic Adenocarcinoma Panel for the National Comprehensive Cancer Network. He has served numerous roles for the Society of Surgical Oncology. Dr. Glazer is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Glazer is board certified in Surgery and Complex General Surgical Oncology.

Damanpreet Bedi is a Transplant Surgeon practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 22 years. Dr. Bedi is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Liver Failure, Cholangiocarcinoma (Bile Duct Cancer), Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Bedi is board certified in American Board Of Surgery. Dr. Bedi is currently accepting new patients.

Kimberly Shampain is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Shampain is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Visceromegaly, Ascites, Nonalcoholic Steatohepatitis (NASH), and Muscle Invasive Bladder Cancer. Dr. Shampain is board certified in Diagnostic Radiology.

Laura Nadeau is a Hematologist and an Oncologist practicing medicine in Royal Oak, Michigan. She has been practicing medicine for over 27 years. Dr. Nadeau is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 46 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Adult Immune Thrombocytopenia, Chronic Familial Neutropenia, and Bone Marrow Aspiration. Dr. Nadeau is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Nadeau is currently accepting new patients.

Mohamad Alsibae is a Hepatologist and a Transplant Surgeon practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 27 years. Dr. Alsibae is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Hepatitis, Enlarged Liver, Hepatitis C, and Endoscopy. Dr. Alsibae is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Alsibae is currently accepting new patients.

Ella Kazerooni is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Kazerooni is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 44 other conditions, according to our data. Her clinical expertise encompasses Lung Nodules, Emphysema, Interstitial Lung Disease, Pulmonary Fibrosis, and Transcatheter Aortic Valve Replacement (TAVR).

Giselle Marshall is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Marshall is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Synovial Sarcoma, Rhabdoid Tumor Predisposition Syndrome, Rhabdoid Tumor, and Ganglioneuroblastoma. Dr. Marshall is board certified in Diagnostic Radiology.

William Weadock is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Weadock is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Ureterocele, Visceromegaly, and Undifferentiated Pleomorphic Sarcoma. Dr. Weadock is board certified in Diagnostic Radiology.

Hero Hussain is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Hussain is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Ureterocele, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Prostatectomy. Dr. Hussain is board certified in Diagnostic Radiology.

Jeremy Handel is a Radiologist and an Interventional Radiologist practicing medicine in Royal Oak, Michigan. Dr. Handel is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pelvic Congestion Syndrome, Neuroendocrine Tumor, Visceromegaly, Liver Embolization, and Endoscopy. Dr. Handel is board certified in American Board Of Radiology. Dr. Handel is currently accepting new patients.

Manish Sharma is an Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 22 years. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Liver Cancer, and Pancreatic Cancer. Dr. Sharma is board certified in American Board Of Internal Medicine. Dr. Sharma is currently accepting new patients.

Anum Aslam is a Radiologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 17 years. Dr. Aslam is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Alcoholic Cirrhosis, Ascites, ALK-Positive Non-Small Cell Lung Cancer, and Ureterocele.